Dr. Kubaszky has over 20 years of industry and academic experience in non-clinical study design and management of complex projects, including with cell and gene therapies, biologics, biosimilars, or small-molecule products for a wide variety of indications, as well as multiple routes of administration (e.g., oral, iv, sc, intra-articular, intranasal, intravesical or dermal) and special expertise in radiation safety programs. Dr. Kubaszky successfully implements strategies and solutions for pharmaceutical, biotechnology and radiation safety business segments within the company’s global portfolio and provides strategic scientific, outsourcing, regulatory and hands-on expertise to direct and manage development of a wide variety of products for pharmaceutical, medical device, biotech, chemical and agrochemical companies, nonclinical program management, outsourcing support, and study design and monitoring toxicology and surgery.
She currently serves as the Executive Director of Non-Clinical development at toxCell LLC. Previously she was a Principal Scientific Advisor in the Scientific Advisory Services group in Charles River, after being one of the Principal Scientists/Senior Toxicologists and Senior Director of Business development at Citoxlab (Quebec, Canada), which later became a part of Charles River laboratories. She also acted as the Study Director of numerous pre-clinical toxicology studies with ITR Laboratories.
Dr. Kubaszky holds a PhD in Veterinary Medicine from University of Agriculture and Veterinary Medicine, Bucharest, Romania and is a certified toxicologist (DABT, Diplomate of the American Board of Toxicology).